Immune Modulation in Hematologic Malignancies

Seminars in Oncology
Madhav V Dhodapkar, Kavita M Dhodapkar

Abstract

The therapeutic potential of the immune system in the context of hematologic malignancies has long been appreciated particularly due to the curative impact of allogeneic hematopoietic stem cell transplantation (SCT). The role of immune system in shaping the biology and evolution of these tumors is now well recognized. While the contribution of the immune system in anti-tumor effects of certain therapies such as immune-modulatory drugs and monoclonal antibodies active in hematologic malignancies is quite evident, the immune system has also been implicated in anti-tumor effects of other targeted therapies. The horizon of immune-based therapies in hematologic malignancies is rapidly expanding with promising results from immune-modulatory drugs, immune-checkpoint blockade, and adoptive cellular therapies, including genetically-modified T cells. Hematologic malignancies present distinct issues (relative to solid tumors) for the application of immune therapies due to differences in cell of origin/developmental niche of tumor cells, and patterns of involvement such as common systemic involvement of secondary lymphoid tissues. This article discusses the rapidly changing landscape of immune modulation in hematologic malignancies and emp...Continue Reading

References

Sep 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Madhav V DhodapkarKara Olson
Jun 11, 2003·The Journal of Experimental Medicine·Madhav V DhodapkarJoseph Krasovsky
Nov 19, 2004·The New England Journal of Medicine·Sandeep S DaveLouis M Staudt
Aug 2, 2006·The Journal of Experimental Medicine·Anjli KukrejaMadhav V Dhodapkar
Dec 26, 2006·Nature Medicine·Michel ObeidGuido Kroemer
Mar 29, 2007·The Journal of Experimental Medicine·Radek SpisekMadhav V Dhodapkar
Mar 24, 2009·Lancet·Louis M WeinerSoldano Ferrone
May 6, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arnold FreedmanPaul Hamlin
Oct 8, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephen M AnsellJohn M Timmerman
Feb 16, 2010·Nature Reviews. Immunology·Koji TokoyodaAndreas Radbruch
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William G WierdaUNKNOWN Hx-CD20-406 Study Investigators
Mar 23, 2010·Cell·Laurence ZitvogelGuido Kroemer
Mar 31, 2010·Seminars in Hematology·Stephen A BeersMartin J Glennie
Jul 16, 2010·Proceedings of the National Academy of Sciences of the United States of America·Viggo F Van TendelooZwi N Berneman
Nov 5, 2010·The New England Journal of Medicine·Anas YounesAndres Forero-Torres
Dec 2, 2010·JAMA : the Journal of the American Medical Association·Ryszard M PlutaRichard M Glass
Jun 3, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen J SchusterLarry W Kwak
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sagar LonialSundar Jagannath
Aug 22, 2012·International Journal of Cancer. Journal International Du Cancer·Daniel SommermeyerWolfgang Uckert
Aug 31, 2012·The New England Journal of Medicine·Jeffrey M VenstromKatharine C Hsu
Jan 11, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Kelli P MacDonaldPavan Reddy
Mar 27, 2013·The New England Journal of Medicine·Stephan A GruppCarl H June
May 18, 2013·Nature Reviews. Immunology·Stuart G TangyeElissa K Deenick
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol

❮ Previous
Next ❯

Citations

May 26, 2016·Expert Opinion on Biological Therapy·Myrna R Nahas, David Avigan
Sep 24, 2016·Journal for Immunotherapy of Cancer·Luca Castagna, Domenico Mavilio
Sep 18, 2016·Critical Reviews in Oncology/hematology·Wanyan OuyangZhi Wang
Dec 8, 2017·Journal of Biomaterials Science. Polymer Edition·Samad Hosseini SadrAli Ramazani
Mar 24, 2017·Journal for Immunotherapy of Cancer·David F StroncekBarbara Seliger
Oct 1, 2015·Aging·Alison Sehgal, Michael Boyiadzis
Jul 6, 2018·Journal of Hematology & Oncology·Dimitri KasakovskiYangqiu Li
Apr 27, 2018·Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation·Mani RamziBita Geramizadeh
May 1, 2021·Journal of Clinical Medicine·Alejandro Olivares-HernándezJosé Pablo Miramontes-González

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Annual Review of Immunology
Michael Dougan, Glenn Dranoff
[Rinshō ketsueki] The Japanese journal of clinical hematology
Yoshio Katayama
Artificial Cells, Nanomedicine, and Biotechnology
Tohid KazemiMehdi Yousefi
Immunological Reviews
Michelle H Nelson, Chrystal M Paulos
© 2021 Meta ULC. All rights reserved